ICCCIMMUCELL CORP /DE/

Nasdaq immucell.com


$ 3.85 $ -0.01 (-0.26 %)    

Tuesday, 10-Sep-2024 15:49:52 EDT
QQQ $ 468.28 $ 9.96 (2.17 %)
DIA $ 409.73 $ 1.01 (0.25 %)
SPY $ 554.79 $ 5.63 (1.03 %)
TLT $ 100.61 $ -0.08 (-0.08 %)
GLD $ 232.25 $ -0.37 (-0.16 %)
$ 3.79
$ 3.90 x 100
-- x --
-- - --
$ 3.50 - $ 5.64
15,309
na
29.6M
$ -0.08
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-13-2024 06-30-2024 10-Q
2 05-14-2024 03-31-2024 10-Q
3 04-01-2024 12-31-2023 10-K
4 11-13-2023 09-30-2023 10-Q
5 08-10-2023 06-30-2023 10-Q
6 05-11-2023 03-31-2023 10-Q
7 03-29-2023 12-31-2022 10-K
8 11-21-2022 09-30-2022 10-Q
9 08-11-2022 06-30-2022 10-Q
10 05-12-2022 03-31-2022 10-Q
11 03-30-2022 12-31-2021 10-K
12 11-15-2021 09-30-2021 10-Q
13 08-12-2021 06-30-2021 10-Q
14 05-13-2021 03-31-2021 10-Q
15 03-30-2021 12-31-2020 10-K
16 11-12-2020 09-30-2020 10-Q
17 08-12-2020 06-30-2020 10-Q
18 05-13-2020 03-31-2020 10-Q
19 03-27-2020 12-31-2019 10-K
20 11-12-2019 09-30-2019 10-Q
21 08-12-2019 06-30-2019 10-Q
22 05-13-2019 03-31-2019 10-Q
23 03-22-2019 12-31-2018 10-K
24 11-13-2018 09-30-2018 10-Q
25 08-13-2018 06-30-2018 10-Q
26 05-14-2018 03-31-2018 10-Q
27 03-29-2018 12-31-2017 10-K
28 11-13-2017 09-30-2017 10-Q
29 08-14-2017 06-30-2017 10-Q
30 05-11-2017 03-31-2017 10-Q
31 03-30-2017 12-31-2016 10-K
32 11-10-2016 09-30-2016 10-Q
33 08-11-2016 06-30-2016 10-Q
34 05-11-2016 03-31-2016 10-Q
35 03-25-2016 12-31-2015 10-K
36 11-12-2015 09-30-2015 10-Q
37 08-13-2015 06-30-2015 10-Q
38 05-12-2015 03-31-2015 10-Q
39 03-26-2015 12-31-2014 10-K
40 11-12-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 immucell-updates-regulatory-status-of-product-development-initiative-for-re-tain

ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develop...

 immucell-reports-preliminary-unaudited-sales-results-for-q1-2024-of-73m-up-111-yy

Total sales during the twelve-month period ended March 31, 2024 were 33% more than the twelve-month period ended March 31, 2023.

 earnings-scheduled-for-february-27-2024

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on rev...

 immucell-q3-2023-gaap-eps-012-down-from-008-yoy-sales-540m-up-from-480m-yoy

ImmuCell (NASDAQ:ICCC) reported quarterly losses of $(0.12) per share. This is a 50 percent decrease over losses of $(0.08) per...

 earnings-scheduled-for-november-13-2023

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr...

 immucell-announces-preliminary-unaudited-sales-results-for-q3-2023-sees-q3-revenue-54m-vs-48m-yoy

 ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures...

 immucell-q2-eps-018-down-from-009-yoy-sales-353m-down-from-386m-yoy

ImmuCell (NASDAQ:ICCC) reported quarterly losses of $(0.18) per share. This is a 100 percent decrease over losses of $(0.09) pe...

 earnings-scheduled-for-august-10-2023

Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share o...

 why-immucell-are-trading-higher-here-are-20-stocks-moving-premarket

Gainers Cadrenal Therapeutics, Inc. (NASDAQ: CVKD) shares surged 131.6% to $4.03 in pre-market trading after gaining 15% on ...

 angiodynamics-disney-and-3-stocks-to-watch-heading-into-wednesday

With U.S. stock futures trading slightly higher this morning on Wednesday, some of the stocks that may grab investor focus toda...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION